Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 1/2013

01-01-2013 | Special Article

Pregnancy in women with hypertrophic cardiomyopathy

Auteurs: P. G. Pieper, F. Walker

Gepubliceerd in: Netherlands Heart Journal | Uitgave 1/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Hypertrophic cardiomyopathy (HCM) is increasingly being diagnosed in pregnant women. Women with HCM generally tolerate pregnancy well. The risk is however higher in women who are symptomatic before pregnancy or in those with severe left ventricular outflow tract obstruction. The incidence of arrhythmias does not appear to be increased during pregnancy and maternal mortality is low. Prior to conception, women with HCM should have a risk assessment as well as genetic counselling. During pregnancy beta-blockers should be continued and the judicious use of diuretics may be required to treat symptoms of dyspnoea. A vaginal delivery with regional anaesthesia is usually appropriate. Women should be managed by a specialist multidisciplinary team.
Literatuur
1.
go back to reference Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96:872–8.PubMedCrossRef Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96:872–8.PubMedCrossRef
2.
go back to reference Drenthen W, Boersma E, Balci A, et al. On behalf of the ZAHARA investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.PubMedCrossRef Drenthen W, Boersma E, Balci A, et al. On behalf of the ZAHARA investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.PubMedCrossRef
3.
go back to reference Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.PubMedCrossRef Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.PubMedCrossRef
4.
go back to reference Christiaans I, Nannenberg EA, Dooijes D, et al. Founder mutations in hypertrophic cardiomyopathy in the Netherlands. Neth Heart J. 2010;18:248–54.PubMedCrossRef Christiaans I, Nannenberg EA, Dooijes D, et al. Founder mutations in hypertrophic cardiomyopathy in the Netherlands. Neth Heart J. 2010;18:248–54.PubMedCrossRef
5.
go back to reference Christiaans I, Birnie E, Bonsel GJ, et al. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. Eur Heart J. 2011;32:1161–70.PubMedCrossRef Christiaans I, Birnie E, Bonsel GJ, et al. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. Eur Heart J. 2011;32:1161–70.PubMedCrossRef
6.
go back to reference Van den Wijngaard A, Volders P, van Tintelen JP. Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Neth Heart J. 2011;19:344–51.PubMedCrossRef Van den Wijngaard A, Volders P, van Tintelen JP. Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Neth Heart J. 2011;19:344–51.PubMedCrossRef
8.
9.
go back to reference Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142:e153–203.PubMedCrossRef Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142:e153–203.PubMedCrossRef
10.
go back to reference Krul SPJ, Smagt JJ, van den Berg MP, et al. Systematic review of pregnancy in women with inherited crdiomyopathies. Eur J Heart Fail. 2011;13:584–94.PubMedCrossRef Krul SPJ, Smagt JJ, van den Berg MP, et al. Systematic review of pregnancy in women with inherited crdiomyopathies. Eur J Heart Fail. 2011;13:584–94.PubMedCrossRef
11.
go back to reference Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011;32:3147–97.PubMedCrossRef Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011;32:3147–97.PubMedCrossRef
12.
go back to reference Van Langen IM, Arens Y, Baars H, et al. ICIN working group on Hereditary Heart Diseases. Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM). Neth Heart J. 2010;18:144–59.CrossRef Van Langen IM, Arens Y, Baars H, et al. ICIN working group on Hereditary Heart Diseases. Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM). Neth Heart J. 2010;18:144–59.CrossRef
13.
go back to reference Pieper PG. Pre-pregnancy risk assessment and counseling of the cardiac patient. Neth Heart J. 2011;19:477–81.PubMedCrossRef Pieper PG. Pre-pregnancy risk assessment and counseling of the cardiac patient. Neth Heart J. 2011;19:477–81.PubMedCrossRef
14.
go back to reference Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.PubMedCrossRef Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.PubMedCrossRef
15.
go back to reference Autore C, Conte MR, Piccinno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:1864–9.PubMedCrossRef Autore C, Conte MR, Piccinno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:1864–9.PubMedCrossRef
16.
go back to reference Thaman R, Varnava A, Hamid MS, et al. Pregnancy related complications in women with hyprtrophic cardiomyopathy. Heart. 2003;89:752–6.PubMedCrossRef Thaman R, Varnava A, Hamid MS, et al. Pregnancy related complications in women with hyprtrophic cardiomyopathy. Heart. 2003;89:752–6.PubMedCrossRef
17.
go back to reference Avila WS, Amaral FMC, Ramires JAF, et al. Influence of pregnancy on clinical course and fetal outcome of women wit hypertrophic cardiomyopathy. Arq Bras Cardiol. 2007;88:423–8.CrossRef Avila WS, Amaral FMC, Ramires JAF, et al. Influence of pregnancy on clinical course and fetal outcome of women wit hypertrophic cardiomyopathy. Arq Bras Cardiol. 2007;88:423–8.CrossRef
18.
go back to reference Schuler PK, Herrey A, Wade A, et al. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Europace 2012; doi:10.1093/europace/eus172. Schuler PK, Herrey A, Wade A, et al. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Europace 2012; doi:10.​1093/​europace/​eus172.
19.
go back to reference Tromp CHN, Nanne ACM, Pernet PJM, et al. Electrical cardioversion during pregnancy: safe or not? Neth Heart J. 2011;19:134–6.PubMedCrossRef Tromp CHN, Nanne ACM, Pernet PJM, et al. Electrical cardioversion during pregnancy: safe or not? Neth Heart J. 2011;19:134–6.PubMedCrossRef
20.
go back to reference Pieper PG. The pregnant woman with heart disease: management of pregnancy and delivery. Neth Heart J. 2012;20:33–7.PubMedCrossRef Pieper PG. The pregnant woman with heart disease: management of pregnancy and delivery. Neth Heart J. 2012;20:33–7.PubMedCrossRef
21.
go back to reference Walker D, Kaur N, Bell R, et al. Hypertrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. Minerva Anestesiol. 2007;73:485–586.PubMed Walker D, Kaur N, Bell R, et al. Hypertrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. Minerva Anestesiol. 2007;73:485–586.PubMed
22.
go back to reference Ferguson EA, Paech MJ, Veltman MG. Hypertrophic cardiomyopathy and caesarean section: intraoperative use of transthoracic echocardiography. Int J Obst Anesth. 2006;15:311–6.CrossRef Ferguson EA, Paech MJ, Veltman MG. Hypertrophic cardiomyopathy and caesarean section: intraoperative use of transthoracic echocardiography. Int J Obst Anesth. 2006;15:311–6.CrossRef
Metagegevens
Titel
Pregnancy in women with hypertrophic cardiomyopathy
Auteurs
P. G. Pieper
F. Walker
Publicatiedatum
01-01-2013
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 1/2013
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-012-0358-7

Andere artikelen Uitgave 1/2013

Netherlands Heart Journal 1/2013 Naar de uitgave